Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fuji
Queensland Health
Julphar
Chinese Patent Office
McKesson
US Department of Justice
Accenture
Citi
Cipla

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,958,951

« Back to Dashboard

Summary for Patent: 5,958,951
Title: Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
Abstract:The present invention provides R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride in its pure and stable anhydrous form.
Inventor(s): Ahrndt; Preben (.O slashed.lstykke, DK), Petersen; Henning B.o slashed.rge (Lyngby, DK), Chang; Vincent H. (Lake Forest, IL), Allen; Kimberly Ann (Silver Lake, WI), Cain; Michael H. (Grayslake, IL)
Assignee: Novo Nordiskials (Bagsvoerd, DK)
Application Number:08/872,380
Patent Claim Types:
see list of patent claims
Compound; Process; Formulation; Composition; Use;

Drugs Protected by US Patent 5,958,951

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,958,951

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark0661/96Jun 14, 1996

International Patents Family Members for US Patent 5,958,951

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 008236 ➤ Try a Free Trial
Austria 223405 ➤ Try a Free Trial
Australia 3165397 ➤ Try a Free Trial
Australia 723267 ➤ Try a Free Trial
Brazil 9709725 ➤ Try a Free Trial
Canada 2257931 ➤ Try a Free Trial
China 1636565 ➤ Try a Free Trial
Czech Republic 295578 ➤ Try a Free Trial
Czech Republic 9804019 ➤ Try a Free Trial
Germany 69715196 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Daiichi Sankyo
Merck
Federal Trade Commission
Queensland Health
Cipla
Julphar
Baxter
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot